Cumberland Partners Ltd Increases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Cumberland Partners Ltd lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 71,607 shares of the healthcare conglomerate’s stock after purchasing an additional 7,263 shares during the period. UnitedHealth Group accounts for approximately 3.1% of Cumberland Partners Ltd’s investment portfolio, making the stock its 7th biggest holding. Cumberland Partners Ltd’s holdings in UnitedHealth Group were worth $36,484,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Caliber Wealth Management LLC increased its stake in UnitedHealth Group by 3.3% during the 3rd quarter. Caliber Wealth Management LLC now owns 5,060 shares of the healthcare conglomerate’s stock worth $2,551,000 after acquiring an additional 161 shares during the period. Vanderbilt University acquired a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $1,520,000. RFG Advisory LLC boosted its holdings in shares of UnitedHealth Group by 27.0% during the 3rd quarter. RFG Advisory LLC now owns 6,524 shares of the healthcare conglomerate’s stock valued at $3,290,000 after acquiring an additional 1,386 shares in the last quarter. WoodTrust Financial Corp boosted its holdings in shares of UnitedHealth Group by 0.3% during the 3rd quarter. WoodTrust Financial Corp now owns 21,609 shares of the healthcare conglomerate’s stock valued at $10,895,000 after acquiring an additional 59 shares in the last quarter. Finally, Independence Bank of Kentucky boosted its holdings in shares of UnitedHealth Group by 14.9% during the 3rd quarter. Independence Bank of Kentucky now owns 3,908 shares of the healthcare conglomerate’s stock valued at $1,970,000 after acquiring an additional 507 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of several recent research reports. Bank of America reaffirmed a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 10th. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Finally, Truist Financial reissued a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $4.86 during midday trading on Tuesday, reaching $486.37. The company’s stock had a trading volume of 3,645,655 shares, compared to its average volume of 4,543,351. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The firm has a 50 day moving average price of $487.49 and a 200-day moving average price of $514.76. The stock has a market capitalization of $448.40 billion, a P/E ratio of 29.73, a PEG ratio of 1.38 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the previous year, the business earned $6.26 EPS. The company’s revenue was up 8.6% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.55%. UnitedHealth Group’s payout ratio is 45.97%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.